The Flow Dependent Adhesion of von Willebrand Factor (VWF)-A1 Functionalized Nanoparticles in an in Vitro Coronary Stenosis Model.
atherothrombosis
drug delivery
nanoparticle adhesion
von Willebrand factor
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
24 Jul 2019
24 Jul 2019
Historique:
received:
10
06
2019
revised:
16
07
2019
accepted:
23
07
2019
entrez:
27
7
2019
pubmed:
28
7
2019
medline:
3
1
2020
Statut:
epublish
Résumé
In arterial thrombosis, von Willebrand factor (VWF) bridges platelets to sites of vascular injury. The adhesive properties of VWF are controlled by its different domains, which may be engineered into ligands for targeting nanoparticles to vascular injuries. Here, we functionalized 200 nm polystyrene nanoparticles with the VWF-A1 domain and studied their spatial adhesion to collagen or collagen-VWF coated, real-sized coronary stenosis models under physiological flow. When VWF-A1 nano-particles (A1-NPs) were perfused through a 75% stenosis model coated with collagen-VWF, the particles preferentially adhered at the post stenotic region relative to the pre-stenosis region while much less adhesion was detected at the stenosis neck (~ 65-fold less). When infused through collagen-coated models or when the A1 coating density of nanoparticles was reduced by 100-fold, the enhanced adhesion at the post-stenotic site was abolished. In a 60% stenosis model, the adhesion of A1-NPs to collagen-VWF-coated models depended on the location examined within the stenosis. Altogether, our results indicate that VWF-A1 NPs exhibit a flow-structure dependent adhesion to VWF and illustrate the important role of studying cardiovascular nano-medicines in settings that closely model the size, geometry, and hemodynamics of pathological environments.
Identifiants
pubmed: 31344782
pii: molecules24152679
doi: 10.3390/molecules24152679
pmc: PMC6696590
pii:
doi:
Substances chimiques
Recombinant Proteins
0
von Willebrand Factor
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Israel Science Foundation
ID : 902/18
Références
J Biol Chem. 1999 Mar 5;274(10):6586-93
pubmed: 10037753
Nat Struct Biol. 2000 Oct;7(10):881-4
pubmed: 11017197
Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):425-30
pubmed: 11756664
Arterioscler Thromb Vasc Biol. 2002 Feb 1;22(2):329-34
pubmed: 11834537
Eur Heart J. 2004 Jul;25(14):1197-207
pubmed: 15246637
Thromb Res. 2007;120 Suppl 1:S5-9
pubmed: 17493665
Nat Med. 2009 Jun;15(6):665-73
pubmed: 19465929
Nat Immunol. 2011 Mar;12(3):204-12
pubmed: 21321594
Atherosclerosis. 2011 Aug;217(2):364-70
pubmed: 21601207
Adv Mater. 2012 Jul 24;24(28):3864-9
pubmed: 22641451
Anal Biochem. 1990 Feb 15;185(1):131-5
pubmed: 2344038
PLoS One. 2013 Sep 03;8(9):e73518
pubmed: 24019925
Blood. 2014 Aug 28;124(9):1412-25
pubmed: 24928861
JAMA Neurol. 2015 Jan;72(1):119-22
pubmed: 25365638
Int J Prev Med. 2014 Aug;5(8):927-46
pubmed: 25489440
J Vasc Surg. 2015 Apr;61(4):1068-80
pubmed: 25704412
Sci Rep. 2015 Jun 26;5:11631
pubmed: 26113000
Circulation. 2019 Mar 5;139(10):e56-e528
pubmed: 30700139
Blood Adv. 2019 Apr 9;3(7):957-968
pubmed: 30936056
Curr Med Chem. 2019;26(13):2285-2296
pubmed: 30963961
Circulation. 1988 Dec;78(6):1431-42
pubmed: 3263902
Circulation. 1984 Dec;70(6):917-22
pubmed: 6499147
Circulation. 1980 Aug;62(2):240-8
pubmed: 7397965
FASEB J. 1993 Feb 1;7(2):308-16
pubmed: 8440408
Arterioscler Thromb Vasc Biol. 1997 Apr;17(4):646-53
pubmed: 9108776
Structure. 1997 Sep 15;5(9):1147-56
pubmed: 9331419
Blood. 1997 Dec 1;90(11):4413-24
pubmed: 9373252